Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | OTC | P00480 | 1/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | ARG2 | P78540 | 4/20 | 0.46 |
| ▸ | ARG1 | P05089 | 3/20 | 0.46 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 4/20 | 0.45 |
| ▸ | NOS1 | P29475 | 3/20 | 0.45 |
| ▸ | NOS3 | P29474 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14095770 | 1.00 | EPHX1 (0.52) | EPHX1GSROTCDPP7ARG2 | |
| SCHEMBL13057095 | 1.00 | EPHX1 (0.52) | EPHX1GSROTCDPP7ARG2 | |
| SCHEMBL16326675 | 0.95 | OTC (0.54) | EPHX1GSROTCDPP7ARG2 | |
| SCHEMBL22195180 | 0.87 | SLC1A1 (0.43) | EPHX1GSROTCDDAH1CYP1A2 | |
| Hydrochloric Acid SCHEMBL21518376 | 0.85 | GGT1 (0.42) | EPHX1GSROTCDDAH1CYP1A2 | |
| Hydrochloric Acid SCHEMBL21518377 | 0.85 | GGT1 (0.42) | EPHX1GSROTCDDAH1CYP1A2 | |
| SCHEMBL19966782 | 0.85 | DPP7 (0.46) | GSROTCDPP7ARG2ARG1 | |
| SCHEMBL19966770 | 0.85 | GSR (0.46) | GSROTCDPP7ARG2ARG1 | |
| SCHEMBL10017793 | 0.85 | DPP7 (0.46) | GSROTCDPP7ARG2ARG1 | |
| SCHEMBL20670726 | 0.84 | ACHE (0.47) | GSROTCDPP7DDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667483-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING PEPTIDE | JCR Pharmaceuticals Co., Ltd. (JP) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024172166-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING PEPTIDE | ＪＣＲファーマ株式会社 | 2024-08-22 | — | — | WO | disclosed |
| US-20230321267-A1 | Method And Molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-12 | — | — | US | disclosed |
| US-11759526-B2 | Method and molecules | MEDIMMUNE, LLC (US) | 2023-09-19 | — | — | US | disclosed |
| WO-2023022234-A1 | HUMAN TRANSFERRIN RECEPTOR–BINDING PEPTIDE | ペプチドリーム株式会社 | 2023-02-23 | — | — | WO | disclosed |
| US-20210290682-A1 | Functionalized Erythroid Cells | RUBIUS THERAPEUTICS, INC. (US) | 2021-09-23 | — | — | US | disclosed |
| US-20210283141-A1 | PYRROLOBENZODIAZEPINE CONJUGATES | MEDIMMUNE LIMITED (GB) | 2021-09-16 | — | — | US | disclosed |
| US-11020435-B2 | Functionalized erythroid cells | RUBIUS THERAPEUTICS, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| WO-2021082882-A1 | METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF LIVING CELL | 中国药科大学 | 2021-05-06 | — | — | WO | disclosed |
| US-20200206359-A1 | Method And Molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-07-02 | — | — | US | disclosed |
| US-9968690-B2 | Norbornene modified peptides and their labelling with tetrazine compounds | MEDICAL RESEARCH COUNCIL (GB) | 2018-05-15 | — | — | US | disclosed |
| US-5079167-A | Enzymatic resolution of amino acid carbamate racemates | GESELLSCHAFT FUR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) (DE) | 1992-01-07 | — | — | US | disclosed |
| EP-0243606-A1 | Process for enzymatic racemate cleavage | Gesellschaft für Biotechnologische Forschung mbH (GBF) (DE) | 1987-11-04 | — | — | EP | disclosed |
| WO-1987005329-A1 | PROCESS FOR THE SEPARATION OF RACEMATES | GESELLSCHAFT FÜR BIOTECHNOLOGISCHE FORSCHUNG MBH ( (DE) | 1987-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200206359-A1 | Method And Molecules | PAICS, EPCAM, SQLE | EPHX1 377/4885GSR 1413/4885OTC 4403/4885 |
| US-20230321267-A1 | Method And Molecules | PAICS, EPCAM, SQLE | EPHX1 377/4885GSR 1413/4885OTC 4403/4885 |
| US-20210290682-A1 | Functionalized Erythroid Cells | EPOR, TFRC, CD47 | EPHX1 115/4885GSR 139/4885OTC 2552/4885 |
| US-11759526-B2 | Method and molecules | PAICS, EPCAM, SQLE | EPHX1 377/4885GSR 1413/4885OTC 4403/4885 |
| US-11020435-B2 | Functionalized erythroid cells | EPOR, TFRC, CD47 | EPHX1 115/4885GSR 139/4885OTC 2552/4885 |
| US-20210283141-A1 | PYRROLOBENZODIAZEPINE CONJUGATES | LANCL1, CD79B, FCGR2A | EPHX1 2552/4885GSR 4233/4885OTC 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.